CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ahead of schedule. The ...
Can clinical trials be faster and better? Yes. Here’s how. Put six life science researchers in a room and it’s likely that there will be six different opinions on almost any subject except one: that ...
Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results